Health Care and Biotech
Alcidion’s IT Targets Hospital Efficiency
Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.
Dec 19 2016
Estia Health Beset By Uncertainty
Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.
Dec 13 2016
Rebound For Sirtex
Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.
Dec 13 2016
Sirtex Reaction Overdone
Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.
Dec 12 2016
Previous Stories
Buying Opportunity In CSL
Jul 22 2015
The Chartist reports the technicals are lining up for CSL to gather momentum to the upside.
Sonic Healthcare Outlook Remains Clouded
Jul 21 2015
Sonic Healthcare is the second pathology provider to issue an earnings downgrade in a week, as funding cuts pressure the industry.
Healthscope Best Placed For Insurer Negotiations
Jul 21 2015
Private hospital operator Healthscope is expected to weather insurer rate reductions, given its margins are among the highest in the sector. Morgan Stanley initiates coverage.
Osprey Medical Enjoying Progress
Jul 17 2015
Osprey Medical is making progress with a device to minimise kidney damage when dyes are extensively used in X-ray procedures.
Concern Over Medibank Private’s Outlook
Jul 15 2015
Most brokers expect newly listed Medibank Private to deliver on prospectus forecasts but remain concerned about the outlook for FY16.
Treasure Chest: Cochlear Reinvigorated?
Jul 14 2015
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. JP Morgan has decided it’s time to be more upbeat about Cochlear Ltd, given the company appears to be taking back market share.
Treasure Chest: Market Misunderstanding CSL’s Power Of Four
Jul 07 2015
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Not only is a four-flu vaccine better than a three-flu, it’s 50% more pricey and thus offers a big boost to CSL earnings, UBS points out, which has been overlooked by the market.
Weekly Broker Wrap: Supermarkets, Automotive, Pharma And Banking
Jun 26 2015
Equity strategy; Coles extends lead on Woolworths; Overseas holidays; automotive dealers; pharma wholesalers; banking fee growth; Donaco update.
Weekly Broker Wrap: Property Portals, WA Miners, Builders And A-REITs
Jun 19 2015
Ukraine crops; REA Group vs Domain; WA miners counting costs; home builders buoyant; views on Nib Holdings, Yowie Group; outlook for shopping centres.
Sonic Booms In Europe
Jun 16 2015
Sonic Healthcare will acquire Switzerland’s Medisupport, a deal welcomed by most brokers for the synergies it offers to the European business.
